You just read:

Cornerstone Pharmaceuticals, Inc. Presents Phase I Data on CPI-613 in Acute Myeloid Leukemia (AML) and T-Cell Non-Hodgkin's Lymphoma (T-cell NHL) at ASH 2016

News provided by

Cornerstone Pharmaceuticals

Dec 05, 2016, 21:00 ET